- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
10th Annual Drug Discovery Leaders Summit
Summary
15 Jun 2009-16 Jun 2009 — Montreaux, Switzerland
10th Annual Drug Discovery Leaders Summit attracts 200 senior attendees from the UK, Europe and US's leading pharmaceutical, biotech, academic and research institutions. Topics include R&D Strategies & Systems Biology, Assay Development & Screening and Drug Design & Targets. www.drugdiscovery-summit.com
Contact details
Cerlin Roberts email: c.roberts@oxfordglobal.co.uk phone: +44 (0) 1865 811193
Venue
Montreaux Palace
Summit — 15 Jun Sun-13:00 16 Jun 2008
The 10th Annual Drug Discovery Summit, presented by Oxford Global Conferences, will provide a first class educational and networking opportunity for over 200 attendees from leading pharmaceutical, biotechnology, diagnostics and clinical research companies as well as academic institutions in the UK, Europe and the US. It will take place on the 15 & 16 June 2009, at the Montreux Palace Hotel in Switzerland.
Over two days the comprehensive scientific conference programme will feature keynote addresses, case study presentations, panel and roundtable discussions from over 60 speakers giving insight on how to effectively manage and streamline your Drug Discovery process, whilst reducing attrition rates. Topics being covered at the Summit include:-
R&D STRATEGIES AND DRUG DESIGN & TARGETS
Examining strategies and novel business models to overcome attrition, as well as Insight into the strategies and technologies of drug design, reviewing fragment, NMR techniques as well as case studies of various drug targets
ASSAY DEVELOPMENT & SCREENING TECHNIQUES
Evaluating different cost effective screening methods and proposed techniques to strengthen your assay
PHARMA/BIOTECH ALLIANCES COLLABORATIONS & OUTSOURCING
Achieving a harmonious relationship which benefits all partners is vital in this process, therefore understanding capabilities the perceptions and requirements of both sides are discussed in order to fuel new growth
BIOMARKERS & TRANSLATIONAL MEDICINE
Critical analysis of the impact of biomarkers, in particular within the role of translational and personalised medicine, answering what a validated biomarker really is and the role of imaging and toxicology within this realm
BIOINFORMATICS
Maximising data uptake and integration whilst improving early decision making and lowering attrition though realising the benefit of developing a good infrastructure
2008 speakers included:-
• Global Head of Research, F. Hoffmann-La Roche
• Senior Vice President, Head of Worldwide Research, Pfizer
• Senior Vice President Research and Development, AstraZeneca
• Senior Vice-President, Business Development, Argenta Discovery
• Chief Scientific Officer, Basilea Pharmaceuticals
• Vice President, Drug Discovery, GPC Biotech AG
• Vice President, Safety Evaluation and Risk Management, GlaxoSmithKline
• Vice President, Translational Sciences, MedImmune
• Vice President, New Technology Development, Genzyme
• Vice President NCE Research, UCB Group
• Vice President, Structure-Based Drug Discovery, Rib-X Pharmaceuticals
• Divisional Director, Early Lead Generation & Computational Chemistry, Lundbeck
• Executive Director Medicinal Chemistry, AstraZeneca
• Senior Director, Discovery Technology, Millennium Pharmaceuticals
• Director, Antibody Expression, Symphogen
• Director of Medicinal Chemistry, 7TM Pharma
• Director of Chemistry & Structural Science, Vernalis
• Director, Business Development, Europe, Baxter
• Director Discovery Technologies, Eli Lilly
• Director, Worldwide Business Development, Pfizer
• Director of Research - Technology, MedImmune
• Associate Director, Medicinal Chemistry, Schering-Plough
• Site Director, Molecular Discovery Research, GlaxoSmithKline
• Head of Knowledge Mining and Representation in Systems Biology, Pfizer
• Head of Strategic Alliance Management EU, Novartis
• Head High Throughput Screening, Nycomed
• Head of Department, Screening Technologies and Pharmacology, Institut Pasteur Korea
• Head of Functional Genomics, Boehringer Ingelheim
• Department Head Strategic Innovation & Research Portfolio Management, Merck Serono
• Senior Scientist, Exploratory Development Department, Astellas Pharma Europe B.V
Early bird discounts are available by quoting "DISCDEL01". For information on sponsorship please email sponsorship@oxfordglobal.co.uk or call +44(0) 1865 811196. www.drugdiscovery-summit.com.
Book online at http://www.drugdiscovery-summit.com/event_book.asp.
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us